NAME A/Prof Joseph Rosenbluh
CANCER TYPE General
INSTITUTION Monash University
GRANT TYPE $100,000
PROJECT TYPE Research
PROTACS as a novel therapeutic strategy in colorectal cancer
"We will utilise a new and innovative drug development approach called proteolysis targeting chimera (PROTAC)...By combining our expertise in chemistry, cancer genetics and modelling we will develop PROTACs that target and destroy colorectal driving oncogenes. This will enable a new strategy for colorectal cancer treatment."
- Professor Joseph Rosenbluh, Monash University